Related Experiment Video
Updated: Aug 30, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary
Timothy D Kinnaird1, Eugenio Stabile, Gary S Mintz
1Cardiovascular Research Institute and Cardiac Catheterization Laboratory, Washington Hospital Center, Washington, DC 20010, USA. tim.kinnaird@medstar.net
Insights
Major bleeding after percutaneous coronary intervention (PCI) affects 5.4% of patients, increasing mortality risk. Predictors include intra-aortic balloon pump use, hypotension, and advanced age, highlighting high-risk patient groups.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Bleeding is a frequent complication of percutaneous coronary intervention (PCI).
- Understanding the incidence, predictors, and outcomes of bleeding is crucial for patient management.
- Thrombolysis In Myocardial Infarction (TIMI) criteria are standard for bleeding classification.
Purpose of the Study:
- To investigate the incidence, predictors, and prognostic impact of periprocedural bleeding and transfusion in patients undergoing PCI.
- To identify patient and procedural factors associated with major bleeding.
- To assess the impact of bleeding on in-hospital and long-term mortality.
Main Methods:
- Retrospective analysis of 10,974 patients who underwent PCI.
- Classification of bleeding events into major, minor, and no bleeding based on TIMI criteria and hematocrit changes.
- Multivariate logistic regression to identify predictors of major bleeding.
Main Results:
- Major bleeding occurred in 5.4% of patients, minor bleeding in 12.7%, and no bleeding in 81.9%.
- Patients with major bleeding were older and more likely to experience intraprocedural complications like intra-aortic balloon pump use.
- Strongest predictors for major bleeding included intra-aortic balloon pump use (OR 3.0), procedural hypotension (OR 2.9), and age >80 years (OR 1.9).
- Major bleeding was independently associated with higher in-hospital and 1-year mortality.
Conclusions:
- Periprocedural major bleeding is a common complication of PCI with significant adverse prognostic implications.
- Patients over 80 years old with intraprocedural complications face a particularly high risk of major bleeding.
- Effective risk stratification and management strategies are needed to mitigate bleeding complications and improve outcomes after PCI.
Abstract:
Bleeding related to percutaneous coronary intervention (PCI) occurs relatively frequently. We retrospectively investigated the incidence, predictors, and prognostic impact of periprocedural bleeding and transfusion in 10,974 patients who underwent PCI. Bleeding definitions were based on Thrombolysis In Myocardial Infarction (TIMI) criteria: (1) major bleeding (n = 588; 5.4%): if patients had a hemorrhagic stroke or if hematocrit decreased >15 points or by 10 to 15 points with clinical bleeding; (2) minor bleeding (n = 1,394; 12.7%): if hematocrit decreased <10 points with clinical bleeding or by 10 to 15 points without clinical bleeding; and (3) no bleeding (n = 8,992; 81.9%): if hematocrit decreased <10 points without clinical bleeding. Patients with major bleeding were older than patients with minor or no bleeding (67.8 +/- 11 vs 65.9 +/- 11 vs 63.6 +/- 11 years, respectively; p <0.001) and more often experienced intraprocedural complications, such as emergency use of an intra-aortic balloon pump (13.6% vs 6.5% vs 2.3%, respectively; p <0.001). Multivariate logistic regression analysis identified the use of an intra-aortic balloon pump (odds ratio [OR] 3.0, p <0.0001), procedural hypotension (OR 2.9, p <0.001), and age >80 years (OR 1.9 compared with age <50 years, p = 0.001) as the strongest predictors for major bleeding. Patients who had major bleeding had higher in-hospital and 1-year mortality compared with patients with minor or no bleeding. Bleeding was an independent predictor of in-hospital death. Thus, periprocedural major bleeding occurs relatively frequently and is associated with adverse outcomes. Patients >80 years of age who experience intraprocedural complications are at particularly high risk.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coronary Artery Disease V: Interprofessional Care
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...